The effect of volatile anesthetics on myocardial ischemia/reperfusion: a review and meta-analysis
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 4 (2016),
26 August 2016
,
Page 180-188
https://doi.org/10.22037/jcma.v1i4.13347
Abstract
Introduction: ischemia-reperfusion injury is one of the most important cellular mechanisms involved in myocardial injury; there is a possible protective role for volatile agents on myocardial cells against ischemia-reperfusion injury through inhibition of Ca2+ overload; in this review, the effects of volatile agents on myocardial ischemia-reperfusion were assessed using a meta- analysis methodology.
Materials and methods: from 2007 to 2012, using the following keywords, ischemia reperfusion, volatile agent, volatile anesthetic, preconditioning, myocardial, protection, Sevoflurane, Isoflurane, Desflurane. To select more related studies, the search was made narrower using "ischemia reperfusion" and "volatile agent" to yield in 38 articles which could be entered into study calculations, directly or indirectly, with one of the following indicators: odds ratio, standardized mean reference, relative risk and effect size.
Results: after final screening, 20 articles remaining as related to "the effects of volatile agents on myocardial ischemia/reperfusion". The study demonstrated significant decrease in myocardial ischemic region related to "exposure to volatile agents" (p < 0.01); also, there was not a statistically significant difference between the coverage areas of confidence intervals of 3 different drug doses: 1 MAC; 1.5 MAC and 2 MAC (p value>0.05); at the same time, there was no statistically significant difference regarding the protective effects of volatile anesthetic gases on ischemic outcome (p value>0.05).
Discussion: this study demonstrated that all volatile anesthetics could lead to attenuation of myocardial infarct size; though there is no difference between different doses of volatile agents regarding their protective effects and the protective effects of volatile anesthetics are not different regarding their the main genes involved in cardioprotection
Key words: volatile, ischemia reperfusion, ischemia reperfusion
- volatile
- ischemia reperfusion
How to Cite
References
Solt K, Forman SA. Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol. 2007 Aug;20(4):300-6.
Kojima A, Kitagawa H, Omatsu-Kanbe M, Matsuura H, Nosaka S. Sevoflurane protects ventricular myocytes against oxidative stress-induced cellular Ca(2+) overload and hypercontracture. Anesthesiology. 2013 Sep;119(3):606-20.
Blum FE, Zuo Z. Volatile anesthetics-induced neuroinflammatory and anti-inflammatory responses. Med Gas Res. 2013;3(1):16.
Kojima A, Kitagawa H, Omatsu-Kanbe M, Matsuura H, Nosaka S. Sevoflurane protects ventricular myocytes from Ca2+ paradox-mediated Ca2+ overload by blocking the activation of transient receptor potential canonical channels. Anesthesiology. 2011 Sep;115(3):509-22.
Ma LL, Zhang FJ, Kong FJ, Qian LB, Ma H, Wang JA, et al. Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3beta signals. Shock. 2013 Sep;40(3):217-21.
Ma LL, Zhang FJ, Qian LB, Kong FJ, Sun JF, Zhou C, et al. Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53/RISK/GSK3beta signaling. Int J Cardiol. 2013 Oct 9;168(4):3671-8.
Muntean DM, Ordodi V, Ferrera R, Angoulvant D. Volatile anaesthetics and cardioprotection: lessons from animal studies. Fundam Clin Pharmacol. 2013 Feb;27(1):21-34.
Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One. 2013;8(10):e76652.
Swyers T, Redford D, Larson D. Volatile anesthetic-induced preconditioning. Perfusion. 2013 Sep 3.
Kojima A, Kitagawa H, Omatsu-Kanbe M, Matsuura H, Nosaka S. Presence of store-operated Ca2+ entry in C57BL/6J mouse ventricular myocytes and its suppression by sevoflurane. Br J Anaesth. 2012 Sep;109(3):352-60.
Singh P, Chauhan S, Jain G, Talwar S, Makhija N, Kiran U. Comparison of cardioprotective effects of volatile anesthetics in children undergoing ventricular septal defect closure. World J Pediatr Congenit Heart Surg. 2013 Jan;4(1):24-9.
Kiani A, Mirmohammad Sadeghi M, Gharipour M, Farahmand N, Hoveida L. Preconditioning by isoflurane as a volatile anesthetic in elective coronary artery bypass surgery. ARYA Atheroscler. 2013 May;9(3):192-7.
Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010 Aug 1;106(3):360-8.
Lang XE, Wang X, Zhang KR, Lv JY, Jin JH, Li QS. Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One. 2013;8(2):e52469.
Van Allen NR, Krafft PR, Leitzke AS, Applegate RL, 2nd, Tang J, Zhang JH. The role of Volatile Anesthetics in Cardioprotection: a systematic review. Med Gas Res. 2012;2(1):22.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oct 20;370(9596):1453-7.
Ebrahim S, Clarke M. STROBE: new standards for reporting observational epidemiology, a chance to improve. Int J Epidemiol. 2007 Oct;36(5):946-8.
Brand RA. Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines. Clin Orthop Relat Res. 2009 Jun;467(6):1393-4.
Lewis S, Clarke M. Forest plots: trying to see the wood and the trees. BMJ. 2001 Jun 16;322(7300):1479-80.
Yeh J, D'Amico F. Forest plots: data summaries at a glance. J Fam Pract. 2004 Dec;53(12):1007.
Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008 Oct;14(5):951-7.
Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008 Sep-Oct;11(5):956-64.
Thorlund K, Imberger G, Johnston BC, Walsh M, Awad T, Thabane L, et al. Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses. PLoS One. 2012;7(7):e39471.
Higgins JP. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008 Oct;37(5):1158-60.
Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008 Oct;37(5):1148-57.
Patsopoulos NA, Evangelou E, Ioannidis JP. Heterogeneous views on heterogeneity. Int J Epidemiol. 2009 Dec;38(6):1740-2.
Coory MD. Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2010 Jun;39(3):932; author reply 3.
Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010 May 30;29(12):1282-97.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177-88.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629-34.
Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol. 2002 Feb;31(1):88-95.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006 Feb 8;295(6):676-80.
Riess ML, Costa AD, Carlson R, Jr., Garlid KD, Heinen A, Stowe DF. Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria. Anesth Analg. 2008 Apr;106(4):1049-55, table of contents.
An J, Bosnjak ZJ, Jiang MT. Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels. Anesth Analg. 2007 Nov;105(5):1207-13, table of contents.
Weber NC, Goletz C, Huhn R, Grueber Y, Preckel B, Schlack W, et al. Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases. Eur J Pharmacol. 2008 Sep 11;592(1-3):48-54.
Raphael J, Gozal Y, Navot N, Zuo Z. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010 Apr;55(4):348-57.
Inamura Y, Miyamae M, Sugioka S, Kaneda K, Okusa C, Onishi A, et al. Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta. Anesthesiology. 2009 Nov;111(5):1036-43.
Kaneda K, Miyamae M, Sugioka S, Okusa C, Inamura Y, Domae N, et al. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts. Anesth Analg. 2008 Jan;106(1):9-16, table of contents.
Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y. Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology. 2008 Mar;108(3):415-25.
Inamura Y, Miyamae M, Sugioka S, Domae N, Kotani J. Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion. J Anesth. 2010 Apr;24(2):215-24.
Wang C, Xie H, Liu X, Qin Q, Wu X, Liu H, et al. Role of nuclear factor-kappaB in volatile anaesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion. Eur J Anaesthesiol. 2010 Aug;27(8):747-56.
Fang NX, Yao YT, Shi CX, Li LH. Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts. Mol Biol Rep. 2010 Dec;37(8):3763-9.
Jazbutyte V, Stumpner J, Redel A, Lorenzen JM, Roewer N, Thum T, et al. Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo. PLoS One. 2012;7(8):e42032.
Okusa C, Miyamae M, Sugioka S, Kaneda K, Inamura Y, Onishi A, et al. Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-alpha and epsilon, but not delta, in isolated guinea pig hearts. Eur J Anaesthesiol. 2009 Jul;26(7):582-8.
- Abstract Viewed: 380 times
- PDF Downloaded: 285 times